Epidemiologic trends in pediatric urinary tract infections in United States emergency departments from 2016 to 2023
Clinical and Experimental Emergency Medicine · 2026
DOI: 10.15441/ceem.25.055 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Emergency Medicine, 2026. Verfasst von Michael Gottlieb und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, Rush University Medical Center, Chicago, IL, USA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Objective
Urinary tract infections are a common consideration when assessing pediatric patients with fever. With rising resistance rates and increased focus on antibiotic stewardship, current management needs to be better understood. This study reports the incidence and antibiotic distribution in a nationwide cohort of pediatric emergency department (ED) patients with cystitis and pyelonephritis during an 8-year period.
Methods
We performed a cohort study from January 1, 2016, to December 31, 2023, using Epic Cosmos data. Pediatric ED patients (≤18 years) with an ICD-10 code corresponding to cystitis or pyelonephritis were included. The outcomes were the total number of ED presentations, outpatient antibiotic prescriptions, and antibiotics administered in the ED for patients admitted with cystitis or pyelonephritis. Binary logistic regression models were used to measure the relationship between the year and the dependent variables.
Results
Among 46,774,814 total pediatric ED visits, 730,863 (1.5%) were for cystitis, and 82,717 (0.2%) were for pyelonephritis. Among those admitted, the most common antibiotics were third-generation cephalosporins (cystitis, 55.6%; pyelonephritis, 62.3%), first-generation cephalosporins (cystitis, 13.8%; pyelonephritis, 13.7%), and ampicillin (cystitis, 10.8%; pyelonephritis, 6.6%). First-generation cephalosporin use rose over time, while ampicillin and ciprofloxacin use declined. Among discharged patients, the most common antibiotics were first-generation cephalosporins (cystitis, 43.1%; pyelonephritis, 33.7%), third-generation cephalosporins (cystitis, 20.8%; pyelonephritis, 25.8%), and trimethoprim-sulfamethoxazole (cystitis, 13.5%; pyelonephritis, 11.8%). First-generation cephalosporin use rose over time, while trimethoprim-sulfamethoxazole and ciprofloxacin use declined. Among those with cystitis specifically, the use of third-generation cephalosporins declined over time.
Conclusion
Cystitis and pyelonephritis remain common ED presentations, representing nearly 2% of all pediatric ED visits, and antibiotic selection has shifted notably over time. Understanding the current epidemiology can inform public health planning and antibiotic stewardship in the ED.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Emergency Medicine, Rush University Medical Center, Chicago, IL, USA.
- Rush Medical College, Chicago, IL, USA.
Zitieren
APA
Gottlieb, M., Amponsah, T., Nguyen, N., Shukla, O., Bernard, K., & Moyer, E. (2026). Epidemiologic trends in pediatric urinary tract infections in United States emergency departments from 2016 to 2023. Clinical and Experimental Emergency Medicine. https://doi.org/10.15441/ceem.25.055
Vancouver
Gottlieb M, Amponsah T, Nguyen N, Shukla O, Bernard K, Moyer E. Epidemiologic trends in pediatric urinary tract infections in United States emergency departments from 2016 to 2023. Clinical and Experimental Emergency Medicine. 2026. doi:10.15441/ceem.25.055
BibTeX
@article{Gottlieb2026,
author = {Gottlieb, Michael and Amponsah, Tamara and Nguyen, Nhat and Shukla, Ohm and Bernard, Kyle and Moyer, Eric},
title = {Epidemiologic trends in pediatric urinary tract infections in United States emergency departments from 2016 to 2023},
journal = {Clinical and Experimental Emergency Medicine},
year = {2026},
doi = {10.15441/ceem.25.055}
}
EUVIMED